Digital Pathology Market - Databook 2025 to 2034

The global digital pathology market size was evaluated at USD 1,065 million in 2024 and is expected to grow around USD 3,604 million by 2034, registering a CAGR of 12.96% from 2025 to 2034.

Highlights of the Digital Pathology Market

• North America dominated the digital pathology market in 2024.
• Asia Pacific is expected to show the fastest growth in the forecasted period of 2025-2034.
• By product, the device segment accounted for a considerable share of the market in 2024.
• By product, the software segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By type, the human pathology segment registered its dominance over the market in 2024.
• By type, the veterinary pathology segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By application, the academic research segment maintained a leading position in the market in 2024.
• By application, the disease diagnosis segment is set to experience the fastest rate of market growth from 2025 to 2034.
• By end-use, the hospitals segment registered its dominance over the market in 2024.
• By end-use, the diagnostic labs segment is anticipated to grow with the highest CAGR in the market during the studied years.

Industry Valuation and Growth Rate Projection

Digital pathology utilizes computer applications to aid the microscopy processes to store and distribute images of body tissues, which can help diagnose disease, resulting in an optimized treatment plan. The digital tools utilized can meet these images' storage and distribution needs. Digital pathology provides crucial support to pathologists in diagnosing diseases earlier and more accurately. Healthcare providers are realising the potential of digital pathology in supporting shorter working periods, ultimately leading to better patient care. The market has expanded rapidly due to increased illness levels in the population and an increase in the geriatric demographic. Digitizing pathology means better and faster methods for diagnosing illness lead to better patient outcomes.

Artificial intelligence (AI) applications are also entering the human pathology market, lending services that can allow a pathologist to visualize images more quickly. The digital pathology market appears headed toward an expanding marketplace and beginning to recover from the pandemic (and will) as the access and capacity of the internet, cloud storage availability, and new upload application software are being developed.

Digital Pathology Market: Stats and Figures

• The Semantic Knowledge Extractor Tool (SKET) automatically analyzes pathology reports, saving human workers time. Compared to an expert who requires an average of 30 seconds, these tools allow processing within 3.19 seconds, saving 95.7% of the time required by a pathologist to annotate a report.
• The workforce in the pathology industry is aging, with over 31% of paediatric and perinatal pathologists being over the age of 55, incentivising the use of digital pathology.

How has AI Benefited the Digital Pathology Market?

• Using AI-driven image analysis tools like Paige.AI and PathAI, we can highlight the suspicious cancer cells in tissue slides with extreme accuracy, eliminating any human errors.
• Machine learning algorithms can scan whole slide images (WSIs) faster and correctly illustrate conspicuous parts and areas that pathologists need to focus on appraising first.
• AI is useful in predicting stages of disease, like tumor grading, or how quickly cancer can develop, through analysis of pattern shapes and sizes in cells.
• AI-powered tools have also been used in some hospitals and labs in America to assist in diagnosing breast, prostate, and lung cancers and reduce treatment time.

Industry Leader Announcements

• Martijn Hartjes, Clinical Informatics Business Leader at Philips, said:

"Digital pathology is helping to revolutionize how we diagnose and potentially treat cancer. With the 510(k) approval, we expand our ability to help pathology laboratories transform to fully digital workflows, saving time and easing the burden on pathologists and patients.”

Geographical Insights

North America

North America dominated the digital pathology market in 2024. In the United States and Canada, we have highly developed healthcare models and leading medical technology. Many hospitals in North America, as well as labs, use digital tools that enable pathologists to study tissue samples. This means doctors make faster and better decisions with the digital pathology process. Many prominent companies in the region manufacture digital pathology systems, such as Leica Biosystems and Danaher, and Philips. The FDA has even recently approved digital pathology applications for primary diagnosis, which has provided the market with opportunities to accelerate growth.

Asia-Pacific

Asia-Pacific is anticipated to be the fastest-growing market in the forecasted period of 2025-2034. Countries such as China, India, Japan, and South Korea are already significantly utilizing digital pathology tools in healthcare. Because the population in these countries is located in remote settings, digital pathology is beneficial for physicians to share images for diagnoses and care more quickly. Governments have increased overall spending on hospitals, healthcare facilities, and medical technology. India and China are seeing an increased incidence of cancer and complex/advanced diseases, where physicians need to perform more detailed histopathological analysis of tissues.

Recent Developments

• In July 2024, Philips IntelliSite Pathology Solution received 510 (K) clearance to strengthen Philips's leadership in digital pathology. This shall help the company to improve diagnostics efficiency and accuracy by integrating pathology into a broader IT infrastructure and precision diagnostics systems.

Competitive Landscape

The digital pathology market is highly competitive. Some of the key players in the market include Bionovation Biotech Inc., Morphle Labs Inc., SigTuple Technologies Private Limited, IBEX (IBEX MEDICAL ANALYTICS), AetherAI, West Medica Produktions- und Handles- GmbH (West Medica), HANGZHOU ZHIVEI INFORMATION TECHNOLOGY CO., LTD. (MORPHOGO), and CellaVision.

The digital pathology market is dominated by several companies but the companies that are renowned for their contribution to the market are listed below:

• Company Name: Bionovation Biotech Inc.
• Year of Incorporation: 2017
• Headquarters: San Diego, US

Bionovation Biotech Inc. is a multinational company headquartered in San Diego and is known for providing services for technological innovations to improve digital imaging in pathology.

• Company Name: Morphle Labs Inc.
• Year of Incorporation: 2017
• Headquarters: New York, United States.

Morphle Labs Inc. is a company providing services for the future of cancer diagnostics with first-of-a-kind automation solutions for the cancer diagnostics industry across the globe.

• Company Name: SigTuple Technologies Private Limited
• Year of Incorporation: 2015
• Headquarters: Karnataka

SigTuple Technologies Private Limited is a company providing next-generation solutions by combining the power of microfluidics, robotics, artificial intelligence (AI), and cloud computing, which make quality healthcare delivery affordable and accessible.